Expression of insulin-like growth factor mitogenic signals in adult soft-tissue sarcomas: Significant correlation with malignant potential

Virchows Archiv

Volumn 444, Issue 2, 2004, Pages 142-148

  Busund, Lill Tove R ^a   Ow, Kim T ^b,c   Russell, Pamela ^b,c   Crowe, Philip J ^c   Yang, Jia Lin ^b,c  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

IGF1; IGF1 receptor ; IGF2; IGFBP2; Sarcomas

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; MITOGENESIS; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SOFT TISSUE SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GROWTH SUBSTANCES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; SARCOMA; SIGNAL TRANSDUCTION; SOFT TISSUE NEOPLASMS; SOMATOMEDINS;

EID: 1542285155     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-003-0931-y     Document Type: Article

References (35)

1. American Joint Committee on Cancer (1997) Manual for staging of cancer, 5th edn. Lippincott-Raven, Philadelphia
2. Babajko S, Leneuve P, Loret C, Binoux M (1997) IGF-binding protein-6 is involved in growth inhibition in SH-SY5Y human neuroblastoma cells: its production is both IGF-and cell density-dependent. J Endocrinol 152:221-227
3. Baxter RC, Martin JL (1989) Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res 1:49-68
4. Benjamin RS (1995) Adjuvant chemotherapy of soft tissue sarcomas in North America. Recent Results Cancer Res 138:139-145
5. Blatt J, White C, Dienes S, Friedman H, Foley TP Jr (1984) Production of an insulin-like growth factor by osteosarcoma. Biochem Biophys Res Commun 123:373-376
6. Bourner MJ, Busby WH Jr, Siegel NR, Krivi GG, McCusker RH, Clemmons DR (1992) Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. J Cell Biochem 48:215-226
7. Coindre JM, Terrier P, Bui NB, Bonichon F, Collin F, Le Doussal V, Mandard AM, Vilain MO, Jacquemier J, Duplay H, Sastre X, Barlier C, Henry-Amar M, Mace-Lesech J, Contesso G (1996) Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group. J Clin Oncol 14:869-877
8. Coindre JM, Terrier P, Guillou L, Le Doussal V, Collin F, Ranchere D, Sastre X, Vilain MO, Bonichon F, N'Guyen Bui B (2001) Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 91:1914-1926
9. Cullen KJ, Yee D, Sly WS, Perdue J, Hampton B, Lippman ME, Rosen N (1990) Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 50:48-53
10. Daughaday W (1990) The possible autocrine/paracrine and endocrine roles of insulin growth factors of human tumors. Endocrinology 127:1-4
11. Delhanty PJ, Han VK (1992) The characterization and expression of ovine insulin-like growth factor-binding protein-2. J Mol Endocrinol 9:31-38
12. Einzinger L, Weiss SW (1995) Soft tissue tumors, 3rd edn. Mosby, St. Louis
13. El-Badry OM, Minniti C, Kohn EC, Houghton PJ, Daughaday WH, Helman LJ (1990) Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. Cell Growth Differ 1:325-331
14. Elgin RG, Busby WH Jr, Clemmons DR (1987) An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci U S A 84:3254-3258
15. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 33:459-465
16. Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS (1997) Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab 82:2308-2313
17. Froesch ER, Schmid C, Schwander J, Zapf J (1985) Actions of insulin-like growth factors. Annu Rev Physiol 47:443-467
18. Frustaci S, Gherlinzoni F, De Paoli A, Bonetti M, Azzarelli A, Comandone A, Olmi P, Buonadonna A, Pignatti G, Barbieri E, Apicezmerly H, Serraino D, Picci P (2001) Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol 19:1238-1247
19. Gaynor JJ, Tan CC, Casper ES, Collin CF, Friedrich C, Shiu M, Hajdu SI, Brennan MF (1992) Refinement of clinicopathological staging for localized soft tissue sarcoma of the extremity: a study of 423 adults. J Clin Oncol 10:1317-1329
20. Guillou L, Coindre JM, Bonichon F, Nguyen BB, Terrier P, Collin F, Vilain MO, Mandard AM, Le Doussal V, Leroux A, Jacquemier J, Duplay H, Sastre-Garau X, Costa J (1997) Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 15:350-362
21. Hajdu SI (1979) History and classification of soft tissue tumors. In: Hajdu SI (ed) Pathology of soft tissue tumors. Lea & Febiger, Philadelphia, pp 1-55
22. Ho PJ, Baxter RC (1997) Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Clin Endocrinol 46:333-342
23. Hoeflich A, Yang Y, Huber S, Rascher W, Koepf G, Blum WF, Heinz-Erian P, Kolb HJ, Kiess W (1996) Expression of IGFBP-2, -3, and -4 mRNA during differentiation of Caco-2 colon epithelial cells. Am J Physiol 271:922-931
24. Isaksson OG, Eden S, Jansson JO (1985) Mode of action of pituitary growth hormone on target cells. Annu Rev Physiol 47:483-499
25. Kandel RA, Bell RS, Wunder JS, O'Sullivan B, Catton CN, White LM, Davis AM (1999) Comparison between a 2-and 3-grade system in predicting metastatic-free survival in extremity soft-tissue sarcoma. J Surg Oncol 72:77-82
26. Mathews LS, Norstedt G, Palmiter RD (1986) Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci U S A 83:9343-9347
27. Pollak M, Richard M (1990) Suramin blockade of insulin-like growth factor I-stimulated proliferation of human osteosarcoma cells. J Natl Cancer Inst 82:1349-1352
28. Pollak M, Sem AW, Richard M, Tetenes E, Bell R (1992) Inhibition of metastatic behavior of murine osteosarcoma by hypophysectomy. J Natl Cancer Inst 84:966-971
29. Ravaud A, Bui NB Coindre JM, Lagarde P, Tramond P, Bonichon F, Stockle E, Kantor G, Trojani M, Chauvergne J (1992) Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials. Br J Cancer 66:961-969
30. Resnicoff M, Burgaud JL, Rotman HL, Abraham D, Baserga R (1995) Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res 55:3739-3741
31. Roholl PJ, Skottner A, Prinsen I, Lips CJ, Den Otter W, Van Unnik JA (1990) Expression of insulin-like growth factor 1 in sarcomas. Histopathology 16:455-460
32. Sekyi-Otu A, Bell R, Andrulis I, Pollak M (1994) Metastatic behavior of the RIF-1 murine fibrosarcoma: inhibited by hypophysectomy and partially restored by growth hormone replacement. J Natl Cancer Inst 86:628-632
33. Sekyi-Otu A, Bell RS, Ohashi C, Pollak M, Andrulis IL (1995) Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas. Cancer Res 55:129-134
34. Werner H, Karnieli E, Rauscher FJ, LeRoith D (1996) Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A 93:8318-8323
35. Zhang L, Kashanchi F, Zhan Q, Zhan S, Brady JN, Fornace AJ, Seth P, Helman LJ (1996) Regulation of insulin-like growth factor II P3 promoter by p53: a potential mechanism for tumorigenesis. Cancer Res 56:1367-1373